Condition: Alcohol Use Disorder · Alcohol Dependence · Alcohol Abuse · Sponsor: University of Iowa
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.
This description comes directly from the study's public registry record.
Lindsay E Golden, BS · 319-384-5243 · lindsay-golden@uiowa.edu
Peggy C Nopoulos, MD · 319-356-1144 · peggy-nopoulos@uiowa.edu
Always discuss trial participation with your own doctor first.
| University of Iowa Health Care | Iowa City, Iowa, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06405607